Journal
CLINICAL ENDOCRINOLOGY
Volume 72, Issue 3, Pages 364-370Publisher
WILEY
DOI: 10.1111/j.1365-2265.2009.03639.x
Keywords
-
Categories
Funding
- Hospital for Sick Children Research Institute
- Novo Nordisk Young Investigator Career Development
- Canadian Pediatric Endocrine Group
Ask authors/readers for more resources
P>Background Craniopharyngioma (CP), a tumour occurring in the hypothalamic-pituitary area, results in morbid obesity in 25-60% of affected children. It has been suggested that abnormalities of insulin secretion and/or insulin action due to hypothalamic injury may be associated with weight gain and the metabolic syndrome in this population. Aim To evaluate: (i) insulin secretion (IS) and insulin sensitivity (Si); (ii) features of the metabolic syndrome (MS) and (iii) factors involved in risk for diabetes and heart disease in obese youth treated for CP. Methods Obese subjects treated for CP were compared to BMI-matched control subjects. All subjects underwent anthropometric, blood pressure, resting energy expenditure and body fat assessment. Cholesterol and inflammatory markers, oral glucose tolerance test (OGTT) and frequent sampling intravenous glucose tolerance test (FSIGT), with calculation of IS and Si, were performed. Results Fifteen CP subjects and 15 controls (C) were studied. There were no differences between CP and C for age, gender, BMI or pubertal status. MS was present in 10/15 CP and 3/15 C (P = 0 center dot 03), including impaired glucose tolerance (IGT) in 6/15 CP and 0/15 C (P = 0 center dot 02). Measures of IS, including first and second phase IS, and insulin area-under-the-curve (AUC(ins)) during OGTT, were significantly higher in CP. Si, measured by frequent sampled intravenous glucose tolerance test (Si-FSIGT), was significantly lower in CP subjects (0 center dot 96 +/- 0 center dot 34 vs. 1 center dot 67 +/- 0 center dot 7; P = 0 center dot 01). AUC(ins) was negatively correlated with Si-FSIGT (r = -0 center dot 62; P = 0 center dot 003). Conclusion Children with CP and hypothalamic obesity have more features of MS, increased IS and IGT prevalence and lower Si compared with BMI-matched controls.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available